Examining Counterfeit Drugs and Spurious Medicines: A Need for Vigilance
Thursday, 3 October 2024, 18:56
Understanding the Threat of Counterfeit Drugs
Counterfeit drugs and spurious medicines threaten patient safety and undermine trust in the healthcare system. With estimates indicating over 20% of the USD25 billion Indian market could be compromised, this situation requires urgent attention.
Key Players in Question
- Sun Pharma: A leading name now facing allegations of distributing sub-standard medicines.
- Torrent Pharma: Under investigation for potential risks in their product offerings.
- Alkem: Covert concerns arise about the integrity of their manufacturing processes.
The Impacts of Sub-Standard Drugs
Sub-standard drugs can lead to treatment failures or adverse reactions, raising significant health concerns. Continuous monitoring and regulatory enforcement are vital to combat this issue.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.